|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Dividend income on marketable securities held in Trust Account | ||
| Unrealized gain on marketable securities held in Trust Account | ||
| Allocation of deferred offering cost fort warrant liability | ||
| Change in fair value of warrant liability | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accrued expenses | ||
| Accrued offering costs | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Class B ordinary shares to the Sponsor | ||
| Proceeds from sale of Units | ||
| Payment of underwriting fee | ||
| Proceeds from sale of Private Warrants | ||
| Proceeds from promissory note - related party | ||
| Deferred offering costs from initial public offering | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning | ||
| Cash - Ending | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Fair value adjustment of Class A ordinary shares subject to possible redemption | ||
| Remeasurement of Class A ordinary shares subject to possible redemption | ||
| Initial measurement of public warrants and private placement warrants | ||
| Deferred underwriting fee payable |
Loading...
